Why the world runs on the same standards for medical software
By QualiHQ Team
If you are building software that does something medical -- often called Software as a Medical Device, or SaMD -- and you have started thinking about selling in more than one country, you have probably hit the same worry everyone hits: do I have to learn a different rulebook for every market?
The honest answer is no. Not for the part that actually takes time. The foundation is the same almost everywhere, because the rules are built on international standards, not national ones. Once you see how much is shared, the whole thing gets a lot less intimidating.
The foundation is three standards, and they are international
Strip away the country-specific paperwork and the work of building a compliant medical software product comes down to three things:
- A quality management system -- how you run the company, control changes, handle complaints, manage suppliers. The standard for this is ISO 13485.
- A software lifecycle -- how you plan, build, test, and maintain the software safely. The standard is IEC 62304.
- Risk management -- how you identify what could go wrong and control it. The standard is ISO 14971.
None of those three is a European invention or an American one. They are international standards, written to be used across borders. That is the whole point of them. So when you do this work properly once, you are not doing "EU compliance" or "US compliance." You are doing the work that every major market is built on.
The regulators have spent years deliberately converging
This is not a happy accident. Medical device regulators have been working to line up behind the same standards for over a decade, mostly through a body called the IMDRF (the International Medical Device Regulators Forum). It is the IMDRF that gave us the shared definition of SaMD and the shared way of thinking about software risk that the EU, US, and others now use.
Two concrete examples of how far that has gone:
- MDSAP (the Medical Device Single Audit Program) lets a single ISO 13485-based audit be recognised by five regulators at once: the US FDA, Health Canada, Australia's TGA, Brazil's ANVISA, and Japan's regulators. One audit, five markets.
- The US FDA finished the job in February 2026, when its new Quality Management System Regulation took effect and folded ISO 13485:2016 directly into US law. The old US-only quality rulebook is gone. The US now runs on the same QMS standard as everyone else.
So the direction of travel could not be clearer. The world is converging on one set of foundations, not splitting into more of them.
What actually differs between markets
It would be dishonest to say the markets are identical, so here is the part that genuinely changes: the conformity route. That is the final step where a market checks your evidence and lets you sell.
- In the EU, the lowest-risk class can self-declare; higher classes bring in a notified body.
- In the US, you register with the FDA and, depending on class, may file a 510(k) or a De Novo.
- In Australia, you work with the TGA.
These routes differ, and the class your product falls into differs in the detail. But notice what they all sit on top of: the same QMS, the same software lifecycle, the same risk file. The conformity route is the last mile. The foundation is everything before it, and that foundation travels with you.
Why this matters for a founder
It means you do not have to pick your market before you start, and you do not have to redo your compliance work when you expand. Build the foundation once -- a real ISO 13485 QMS, an IEC 62304 software lifecycle, an ISO 14971 risk file -- and you are building toward every major market at the same time. Choosing the US over the EU, or adding Australia later, changes the last mile, not the road you have already built.
That is a very different mental model from "I need a separate compliance project for each country," and it is the accurate one.
Where QualiHQ fits
The foundation is the same everywhere, but it still has to get built, and that is where most small teams stall. The standards are not the hard part. The documentation and evidence the standards expect is what eats the months, and traditionally the way you got it done was paying a consultant to run workshops and write it up.
QualiHQ does that part for you. You bring your product and your test evidence; QualiHQ reads your documents and your test runs and generates the QMS, the requirements, the risk file, and the traceability that the standards ask for. Because that foundation is international, the same generated QMS is what you take toward the EU, the US, or Australia. You build it once, at a fraction of the cost of a consultant, and you decide your market after, not before.
Compliance feels like five rulebooks. It is really one foundation and a choice of last mile. That is a much smaller problem than it looks.
Not sure where your product even lands yet? Find your likely class and compliance path in a couple of minutes -- free, no signup. Or start building your QMS and see the foundation come together.
Frequently asked questions
Do I need a different QMS for the US and the EU?
No. Both are built on the same international standard, ISO 13485, so the quality system you build works toward either market. Only the final conformity route differs.
Is ISO 13485 now required in the US?
Effectively yes. The FDA Quality Management System Regulation took effect in February 2026 and incorporates ISO 13485:2016, aligning US requirements with the rest of the world.
What is MDSAP?
The Medical Device Single Audit Program lets one ISO 13485-based audit be recognised by five regulators at once: the US, Canada, Australia, Brazil, and Japan.
If I only sell in one country, does this still matter?
Yes. Building the ISO 13485, IEC 62304, and ISO 14971 foundation once means you can expand to other markets later without redoing the work.
Not sure where you stand? Find out in two minutes.